Analyst firms · Oppenheimer · ANTX
Oppenheimer ANTX price target and rating history
AN2 Therapeutics Inc. (ANTX) · Health Care
Oppenheimer rates AN2 Therapeutics Inc. (ANTX) Perform with a $22 price target, as of its latest action on Feb 12, 2024. It has published 3 rating actions on ANTX since April 2022, including 0 upgrades and 1 downgrade.
- Current rating
- Perform
- Price target
- $22
- Median target, all firms
- Too few
- Actions on ANTX
- 3
Oppenheimer price target on ANTX
Every Oppenheimer rating on ANTX
- Feb 12, 2024
- Jul 18, 2022
- Apr 19, 2022
Questions about Oppenheimer and ANTX
- What is Oppenheimer's price target for ANTX?
- Oppenheimer's latest stated price target for AN2 Therapeutics Inc. (ANTX) is $22, from its action on Jul 18, 2022.
- What is Oppenheimer's rating on ANTX?
- Oppenheimer rates ANTX Perform, a neutral rating, as of Feb 12, 2024.
- When did Oppenheimer last change its view on ANTX?
- On Feb 12, 2024, Oppenheimer downgrades to Perform from Outperform.
More ANTX rating histories
All Oppenheimer ratingsANTX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.